VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s): VPTDF

Healthcare Medical Devices

Ventripoint Diagnostics Ltd is a Canada-based medical device company. The Company is engaged in the development and commercialization of diagnostic tools that monitor patients with heart disease. It is developing a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, imaging, and cardiotoxicity in oncology patients. The Company’s Ventripoint Medical System (VMS+) is a diagnostic aid that was developed to provide a point-of-care solution to better communicate the heart’s structure and function without the need for magnetic resonance imaging (MRI). VMS+ enhances ultrasound, providing three-dimensional (3D) technology that allows for visualization of all four chambers of the heart. The system’s proprietary Knowledge Based Reconstruction (KBR) technology creates 3D models of the heart and calculates volumes and ejection fractions equivalent to the gold-standard Magnetic resonance imaging (MRI).

TSXV:VPT - Post by User

VentriPoint Diagnostics Ltd

Bullboard Posts

Comment by banderas1976on Jul 17, 2019 7:10am

94 Views

Post# 29928287

RE:RE:RE:RE:RE:here's the letter re the NR

Hello investors already 5 years in this. a question for you I thought they would sell the new application as pay per view but apparently not anymore? Is that correct?Nowhere I read anything anymore about that? can somebody explain why they changed business model. think the pay per view would bring us a lot more money either way I think by the end of the year we will be much much further because this is really a very good product they brought on the market

Bullboard Posts

Yukon agency detects cyanide near Victoria Gold's Eagle mine